Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
Authors: McCrimmon, Rory J.1 (AUTHOR), Falla, Edel2 (AUTHOR), Sha, Jo Zhou2 (AUTHOR), Alsaleh, Abdul Jabbar Omar3 (AUTHOR), Lew, Elisheva4 (AUTHOR) Elisheva.Lew@sanofi.com, Hudson, Richard5 (AUTHOR), Baxter, Mike5 (AUTHOR), Palmer, Karen5 (AUTHOR)
Source: Diabetes Therapy. Dec2021, Vol. 12 Issue 12, p3217-3230. 14p.
Database: Academic Search Ultimate
Description
ISSN:18696953
DOI:10.1007/s13300-021-01159-y